ERBB2 and breast cancer: Since BC is highly heterogeneous, it is usually classified in five intrinsic molecular subtypes determined by a 50 gene-expression profile (PAM50), that have different clinical and biological characteristics affecting patient outcome (Luminal A, Luminal B, HER2-enriched, Basal-like, and Normal-like) (8).